Clinically relevant bleeding and thrombotic events in non-cirrhotic splanchnic vein thrombosis. Long-term follow up

Highlights • Patients with splanchnic vein thrombosis have a high risk of thrombotic and bleeding events. • Anticoagulant treatment significantly promotes thrombus resolution. • Solid cancer and hypoalbuminemia were associated with a worse survival.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis research 2017-06, Vol.154, p.55-58
Hauptverfasser:	Jara-Palomares, Luis, Marin-Barrera, Lucia, Giraldez-Gallego, Alvaro, Garzon-Benavides, Marta, Elias-Hernández, Teresa, Praena-Fernandez, Juan Manuel, Asensio-Cruz, Maria Isabel, Solier-Lopez, Aurora, Suarez-Valdivia, Lionel, Sanchez-Diaz, Jose Maria, Otero-Candelera, Remedios
Format:	Artikel
Sprache:	eng
Schlagworte:	Female Follow-Up Studies Hematology, Oncology and Palliative Medicine Hemorrhage - drug therapy Hemorrhage - etiology Heparin Humans Male Middle Aged Splanchnic Circulation - drug effects Splanchnic vein thrombosis Thrombosis - drug therapy Vitamin K antagonist
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Patients with splanchnic vein thrombosis have a high risk of thrombotic and bleeding events. • Anticoagulant treatment significantly promotes thrombus resolution. • Solid cancer and hypoalbuminemia were associated with a worse survival.
ISSN:	0049-3848 1879-2472
DOI:	10.1016/j.thromres.2017.03.028